Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 622

1.

The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients.

Demir M, Serin E, Göktürk S, Ozturk NA, Kulaksizoglu S, Ylmaz U.

Eur J Gastroenterol Hepatol. 2008 Jul;20(7):668-73. doi: 10.1097/MEG.0b013e3282f55e1e.

PMID:
18679070
2.

Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.

Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.

J Med Virol. 2007 Oct;79(10):1464-71.

PMID:
17705185
3.

Occult hepatitis B virus infection.

Allain JP.

Transfus Clin Biol. 2004 Feb;11(1):18-25. Review.

PMID:
14980545
4.

[Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].

Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.

Mikrobiyol Bul. 2007 Apr;41(2):227-33. Turkish.

PMID:
17682709
5.
6.

Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.

Toyoda H, Hayashi K, Murakami Y, Honda T, Katano Y, Nakano I, Goto H, Kumada T, Takamatsu J.

J Med Virol. 2004 Jun;73(2):195-9.

PMID:
15122792
7.

Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.

Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.

Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.

PMID:
18584524
8.

High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.

Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM.

J Clin Virol. 2006 Jan;35(1):14-20.

PMID:
15916918
9.

Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.

Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.

Trop Gastroenterol. 2007 Jan-Mar;28(1):19-23.

PMID:
17896605
10.

Italian blood donors with anti-HBc and occult hepatitis B virus infection.

Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.

Haematologica. 2007 Dec;92(12):1664-70.

11.

[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].

Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.

Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67. Korean.

PMID:
18367859
12.

Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?

Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ; APRICOT Investigators.

J Med Virol. 2007 Jun;79(6):694-700.

PMID:
17457912
13.

The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.

Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, Sherman KE.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):309-14.

PMID:
17159656
14.

Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.

Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, Banifazl M, Moradmand-Badie B, Ramezani A.

Intervirology. 2008;51(4):270-4. doi: 10.1159/000160217. Epub 2008 Oct 7.

PMID:
18841029
15.

Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).

Azarkeivan A, Karimi G, Shaiegan M, Maghsudlu M, Tabbaroki A.

Pediatr Hematol Oncol. 2009 Jun;26(4):195-201. doi: 10.1080/08880010902895900.

PMID:
19437322
16.

Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.

Chu CM, Chen YC, Tai DI, Liaw YF.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):535-40. doi: 10.1016/j.cgh.2010.03.006. Epub 2010 Mar 19.

PMID:
20304099
17.

Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.

Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.

J Med Virol. 2009 Mar;81(3):441-5. doi: 10.1002/jmv.21422.

PMID:
19152397
18.

Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen.

Ramia S, Mokhbat J, Ramlawi F, El-Zaatari M.

Int J STD AIDS. 2008 Mar;19(3):197-9. doi: 10.1258/ijsa.2007.007200.

PMID:
18397562
19.

Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea.

Kim SM, Lee KS, Park CJ, Lee JY, Kim KH, Park JY, Lee JH, Kim HY, Yoo JY, Jang MK.

J Infect. 2007 Feb;54(2):185-91. Epub 2006 Mar 27.

PMID:
16564573
20.

High prevalence of occult hepatitis B in Baltimore injection drug users.

Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL.

Hepatology. 2004 Jan;39(1):51-7.

PMID:
14752822

Supplemental Content

Support Center